| November 2023 |
Developing SARS-CoV-2 Main Protease Binding Prediction Random Forest Model for Drug Repurposing for COVID-19 Treatment |
Experimental Biology and Medicine |
10.1177/15353702231209413 |
| October 2023 |
Analyzing 3D Structures of the SARS-CoV-2 Main Protease Reveals Structural Features of Ligand Binding for COVID-19 Drug Discovery |
Drug Discovery Today |
10.1016/j.drudis.2023.103727 |
| June 2023 |
Evaluation of Association of Anti-PEG Antibodies with Anaphylaxis after mRNA COVID-19 Vaccination |
Vaccine |
10.1016/j.vaccine.2023.05.029 |
| February 2023 |
Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and its Interaction with ACE2 and Antibody |
International Journal of Molecular Sciences |
10.3390/ ijms24043774 |
| December 2022 |
Enhanced Virulence and Waning Vaccine-Elicited Antibodies Account for SARS-CoV-2 Delta and Kappa Breakthrough Infections in K18-hACE2 Passive Transfer Model |
iScience |
10.1016/j.isci.2022.105507 |
| November 2022 |
Temporal Dynamics of SARS-CoV-2 Genome and Detection of Variants of Concern in Wastewater Influent from Two Metropolitan Areas in Arkansas |
Science of the Total Environment |
10.1016/j.scitotenv.2022.157546 |
| October 2022 |
Applying Imaging Mass Spectrometry to Define the N-glycan Profiles of Co-localized Virus and Immune Cell Infiltrates in Post-COVID-19 Infected Lung Autopsy Tissues |
Frontiers in Analytical Science |
10.3389/frans.2022.1021008 |
| August 2022 |
Evaluation of the Mutagenic Effects of Molnupiravir and N4-hydroxycytidine in Bacterial and Mammalian Cell by HiFi Sequencing |
Environmental and Molecular Mutagenesis |
10.1002/em.22510 |
| August 2022 |
NeuroCORD: A Language Model to Facilitate COVID-19-Associated Neurological Disorder Studies |
International Journal of Environmental Research and Public Health |
10.1002/em.22510 |
| February 2022 |
AI-Powered Drug Repurposing for Developing COVID-19 Treatments |
Reference Module in Biomedical Sciences |
10.1016/B978-0-12-824010-6.00005-8 |
| November 2021 |
AI-Based Language Models Powering Drug Discovery and Development |
Drug Discovery Today |
10.1016/j.drudis.2021.06.009 |
| July 2021 |
Biochemical Features and Mutations of Key Proteins in SARS-CoV-2 and Their Impacts on RNA Therapeutics |
Biochemical Pharmacology |
10.1016/j.bcp.2021.114424 |
| July 2021 |
Can SARS-CoV-2 Infect the Central Nervous System via the Olfactory Bulb or the Blood-Brain Barrier? |
Brain, Behavior, and Immunity |
10.1016/j.bbi.2020.12.031 |
| July 2021 |
Informing Selection of Drugs for COVID-19 Treatment Through Adverse Events Analysis |
Scientific Reports |
10.1038/s41598-021-93500-5 |
| May 2021 |
Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences |
Viruses |
10.3390/v13050764 |
| March 2021 |
Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data |
Frontiers in Artificial Intelligence |
10.3389/frai.2021.630955 |
| January 2021 |
Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations |
Frontiers in Chemistry |
10.3389/fchem.2020.622632 |
| December 2020 |
Pericytes Within a Pulmonary Neurovascular Unit in COVID-19-elicited Pathologic Changes |
Current Neurovascular Research |
10.2174/1567202617666201222112639 |
| December 2020 |
FDALabel for Drug Repurposing Studies and Beyond |
Nature Biotechnology |
10.1038/s41587-020-00751-0 |
